The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses
Authors:
- Takeshi FujiiTFTakeshi Fujii
- Yuichiro KamimuraYKYuichiro Kamimura
- Koichiro KawashimaKKKoichiro Kawashima
- 1 November 2003
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 144 (1-2) , 46-52
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (14370037)
This publication has 40 references indexed in Scilit:
- The Non-neuronal Cholinergic SystemThe Japanese Journal of Pharmacology, 2001
- Extracellular Signal Regulated Protein Kinase and c-Jun N-Terminal Kinase are Involved in m1 Muscarinic Receptor-Enhanced Interleukin-2 Production Pathway in Jurkat Cells.Biological and Pharmaceutical Bulletin, 2000
- Calcium Signaling and c-Fos Gene Expression via M3 Muscarinic Acetylcholine Receptors in Human T- and B-CellsThe Japanese Journal of Pharmacology, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin AInternational Immunology, 1995
- Detection of choline‐acetyltransferase activity in lymphocytesJournal of Neuroscience Research, 1993
- Changes in the cholinergic system of lymphocytes due to mitogenic stimulationImmunology Letters, 1987
- Radioimmunoassay for acetylcholine in the rat brainJournal of Pharmacological Methods, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975